SP

Sharada Pochampally

Active Director Director DIN 05358193
DIN 05358193 First appointment Aug 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2012
Shareholding value •••• Premium profile

About Sharada Pochampally

Data last updated:

Sharada Pochampally is a Director at Amnean Therapeutics Private Limited (since 2012). The company operates in Pharma. Amnean Therapeutics Private Limited reported revenue of ₹1.16 Cr (FY 2024).

DIN 05358193
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2012
Oldest Company Age 14 yrs
Largest company Amnean Therapeutics Private Limited · ₹1.16 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amnean Therapeutics Private Limited U24232TG2012PTC081046
Director20 Aug 20122012₹1.16 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Amnean Therapeutics Private Limited
Premium access

Shareholding and investment profile for Sharada Pochampally

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharada Pochampally

Sharada Pochampally currently holds 1 directorship: Amnean Therapeutics Private Limited (Director, since 20 Aug 2012, revenue ₹1.16 Cr (FY 2024)).

Sharada Pochampally was first appointed on 20 Aug 2012 as Director at Amnean Therapeutics Private Limited.

The current boards of Sharada Pochampally's companies include Mahaboob Pasha Shaik (Amnean Therapeutics Private Limited), Ramesh Bangalore (Amnean Therapeutics Private Limited), Venkateswara Sastry Srikonda (Amnean Therapeutics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available